About Oxford Science Enterprises
Oxford Science Enterprises is a venture capital firm founded in 2015. It is primarily based out of Oxford, United Kingdom. As of Sep 2026, Oxford Science Enterprises is an active investor, having invested in 121 companies, with 15 new investments in the last 12 months. It primarily invests in Series A round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Seed round of MCatalysis Overall, Oxford Science Enterprises portfolio has seen 3 IPOs and 14 acquisitions including key companies like Oxford Ionics, Barinthus Biotherapeutics and Pepgen. A lot of funds co-invest with Oxford Science Enterprises, with names like Oxford University Innovation sharing a substantial percentage of its portfolio. Oxford Science Enterprises has team of 37 people including 11 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Oxford Science Enterprises' List of Top Investments
Oxford Science Enterprises has a portfolio of 121 companies. Their most notable investments are in Orbit Discovery and BehaVR.Their portfolio spans across United Kingdom, United States, Canada and 3 more locations. They have invested in Life Sciences, High Tech, Enterprise Applications and 27 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Oxford Science Enterprises:1. Perspectum
Developer of medical imaging software for analyzing liver disease biomarkers. This technology extracts quantitative data from magnetic resonance imaging to assist in the assessment of metabolic and chronic conditions. The software provides diagnostic information to support clinical decision-making and patient monitoring. These tools facilitate the interpretation of complex imaging data for medical professionals.
Key facts about Perspectum
- Founded Year: 2012
- Location: Oxford (United Kingdom)
- Annual Revenue: £10M - £50M as on Dec 31, 2024
- Stage: Series C
- Total Funding till date: $140M
- Employee Count: 275 as on Jul 31, 2026
- Investors: Health Quest Capital, Oppenheimer and 32 Others
- Latest Funding Round: Grant (prize money), Sep 17, 2025, $*****
- Highlight: Editors' Pick
2. BibliU
Provider of digital learning content and campus store management solutions. The platform offers institutions tools to automate content workflows and improve learning outcomes. It provides digital textbooks, monographs, and courseware. The platform integrates with existing systems to deliver an interactive learning experience. It supports diverse academic needs of students and faculty.
Key facts about BibliU
- Founded Year: 2014
- Location: Greenville (United States)
- Annual Revenue: £50M - £100M as on Oct 31, 2024
- Stage: Series C
- Total Funding till date: $102M
- Employee Count: 196 as on Jul 31, 2026
- Investors: Oxford Science Enterprises, GSP Capital and 27 Others
- Latest Funding Round: Series C, Jun 02, 2026, $*****
- Highlight: Editors' Pick
Provider of quantum computers. It provides users with superconducting qubits as their physical support for Universal Quantum computers. It offers quantum computers by combining the qubits and trapped ions by using noiseless electronic qubit control technology.
Key facts about Oxford Ionics
- Founded Year: 2019
- Location: Oxford (United Kingdom)
- Stage: Acquired
- Total Funding till date: $48.4M
- Employee Count: 106 as on Jul 31, 2026
- Investors: Lansdowne Partners, Prosus and 10 Others
- Latest Funding Round: Series A, Aug 31, 2023, $*****
- Highlight: Acquired
Developer of T-cell immunotherapeutics to treat multiple diseases. The company has proprietary platform technologies ChAdOx, MVA, SNAP-TI, and SNAP-CI to develop pipeline of product candidates across a diverse range of therapeutic areas including chronic infectious diseases, autoimmunity, and cancer.
Key facts about Barinthus Biotherapeutics
- Founded Year: 2016
- Location: Germantown (United States)
- Annual Revenue: $10M - $50M as on Dec 31, 2024
- Stage: Public
- Total Funding till date: $210M
- Employee Count: 54 as on Nov 14, 2025
- Investors: HTIF, Gilead and 13 Others
- Latest Funding Round: Post IPO, Dec 25, 2023, $*****
- Highlight: Public
5. Prolific
Online platform for finding research participants. It allows researchers to find and engage with research participants. It offers a user interface and a pool of participants from academia, industry, and AI. It enables researchers to launch the studies of participants.
Key facts about Prolific
- Founded Year: 2014
- Location: London (United Kingdom)
- Stage: Series A
- Total Funding till date: $33.8M
- Employee Count: 1,393 as on Jul 31, 2026
- Investors: Oxford Science Enterprises, 10x Value Partners and 5 Others
- Latest Funding Round: Series A, Apr 25, 2023, $*****
- Highlight: Editors' Pick
Oxford Science Enterprises' Year-on-Year Investment Trends
Oxford Science Enterprises has invested in 121 companies over the last 11 years, with an average of 8 new investments annually in the last 10 years. In 2025, it made 12 investments, while as of Sep 2026, it has made 15 investments in this year. Its most recent first time investment was in MCatalysis and most recent follow-on round was in MoA Technology.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 9 | 6 | 15 |
2025 | 9 | 3 | 12 |
2024 | 3 | 8 | 11 |
2023 | 11 | 8 | 19 |
2022 | 9 | 10 | 19 |
2021 | 5 | 12 | 17 |
2020 | 11 | 7 | 18 |
2019 | 6 | 0 | 6 |
2018 | 10 | 7 | 17 |
2017 | 3 | 3 | 6 |
Oxford Science Enterprises' Investments by Stage
Oxford Science Enterprises has made 49 investments in Seed stage with an average round size of $5.08M, 30 investments in Series A stage with an average round size of $21.4M, 10 investments in Series B stage with an average round size of $33M and 1 investment in Series C stage with an average round size of $85M.Stage of entry | No. of Investments |
|---|---|
Seed | 49 |
Series A | 30 |
Series B | 10 |
Series C | 1 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' Investments by Sector
Oxford Science Enterprises has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, HealthTech and Sustainability Tech. Notably, it has invested in 104 Tech companies, 102 Enterprise (B2B) companies, 40 Software companies and at least 40 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 34 |
Enterprise Applications | 28 |
High Tech | 28 |
HealthTech | 17 |
Sustainability Tech | 9 |
Others | 72 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' Investments by Geography
Oxford Science Enterprises has made most investments in United Kingdom (74), followed by United States where it has made 9 investments.Country | No. of Investments |
|---|---|
United Kingdom | 74 |
United States | 9 |
Canada | 1 |
Finland | 1 |
Netherlands | 1 |
Note: We have considered here, only first round of investments
Oxford Science Enterprises' recent investments
Oxford Science Enterprises has made 15 investments in 2026 so far. MCatalysis and Singular Machines are the latest among them.Here are the most recent investments by Oxford Science Enterprises:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 09, 2026 | - | Seed | 7243 | ||
Aug 17, 2026 | United Kingdom | Seed | 8463 | ||
Jul 29, 2026 | United Kingdom | Seed | 8061 | [+1] | |
Jul 28, 2026 | - | Series A | 4057 | - | |
Jul 23, 2026 | United Kingdom | Series C | 6452 | [+5] |
IPOs and Publicly Listed companies in Oxford Science Enterprises' Portfolio
3 of Oxford Science Enterprises' portfolio companies have become public. Pepgen got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in May 2022 at marketcap of $269M and Barinthus Biotherapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $579M.Here are Oxford Science Enterprises' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 06, 2022 | Nov 24, 2020 | Series A | 3681 | |
Apr 30, 2021 | May 12, 2016 | Seed | 6710 | |
- | - | - | 8827 |
Acquired companies in Oxford Science Enterprises' Portfolio
14 companies from Oxford Science Enterprises' portfolio have been acquired. The most recent acquisition was Brill Power in Aug 2025 by Palmer Energy Technology for $*****.Here are Oxford Science Enterprises' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 28, 2025 | Feb 17, 2021 | Seed | 5339 | |
Jun 09, 2025 | Jan 09, 2023 | Series A | 8581 | |
Feb 18, 2025 | - | - | 9421 | |
Jul 16, 2024 | Jun 06, 2019 | Series A | 4456 | |
Oct 20, 2022 | Dec 22, 2020 | Series A | 8957 |
Team profile of Oxford Science Enterprises
Oxford Science Enterprises has a team of 37 members including 11 Partners, 1 Venture Partner and 8 Principals located in United Kingdom, Netherlands and 1 more location. Oxford Science Enterprises' team sits on the board of 2 companies.Here is a list of top team members in Oxford Science Enterprises:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Brussels | - | - | |
Partner | London | - | ||
Partner | Utrecht | - | - | |
Partner | United Kingdom | - | - | |
Partner | Bristol | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | - | - | - | |
Partner | London | - | - |
Co-investors of Oxford Science Enterprises
Over the past 11 years, 411 investors have co-invested in Oxford Science Enterprises's portfolio companies. This includes funds and angels.
- Invested before Oxford Science Enterprises: Parkwalk, Europa and 54 others have invested in rounds before Oxford Science Enterprises. There are 8 companies where Parkwalk has invested before Oxford Science Enterprises and 5 companies where Europa has invested before Oxford Science Enterprises.
- Top Co-investors of Oxford Science Enterprises: 169 investors entered a company along with Oxford Science Enterprises. These include investors like Oxford University Innovation (6 companies).
- Invested after Oxford Science Enterprises: A total of 186 investors have invested in Oxford Science Enterprises's portfolio after their investments. Top Investors include Oxford (12 companies), Oxford University Innovation (6 companies) and Oxford Investment Consultants (5 companies).
Recent News related to Oxford Science Enterprises
•
MCatalysis Raises $5M in Seed FundingFinSMEs•Sep 09, 2026•Oxford Science Enterprises, MCatalysis, Hlenergyventures, Ukri
•
Oxford Spinout Mirae Secures $5.4M to Scale AI Chronic Care PlatformHIT Consultant•Jul 28, 2026•Oxford Science Enterprises
•
Vivid Dx Raises $15M to Combat Drug-Resistant InfectionsPR Newswire•Jul 28, 2026•Vivid Dx, Oxford Science Enterprises, Cedars Sinai
•
•
EQT Life Sciences Participates in RQ Bio's USD 115 Million Series A FinancingPR Newswire•Jun 24, 2026•Frazier Life Sciences, EQT, RQ Bio, Forbion and 6 others
•
Oxford Quantum Circuits Secures Record £260m in European Quantum Computing FundingNew Electronics•Jun 03, 2026•Oqc Tech, Oxford Science Enterprises, Chevron, J P Morgan and 1 other
•
Startup harnessing energy from tides raises £4.3mUKTN•May 27, 2026•Creator Fund, Empirical Ventures, Caudal, Zero Carbon Capital and 3 others
•
•
Quantum Motion Raises $160 Million Series C to Deliver Quantum Computing's "Transistor Moment"Financial Post•May 07, 2026•Quantum Motion, DCVC, Kembara VC, Robert Bosch Venture Capital and 5 others
•
